Biocon Malaysia got UK MHRA approval for its new insulin fill-finish line to support biosimilar Semglee supply in the UK and Europe. The approval covers...
Aurobindo Pharma Ltd on Wednesday reported a 26 percent increase in consolidated net profit at Rs 805.65 crore in the second quarter ended September.The company...
Lupin’s marketing authorization application (MAA) for biosimilar Etanercept has been accepted for review by Europe drug regulator, European Medicines Agency (EMA). MAA means an application submitted by...
Glenmark Pharmaceuticals, for treating plaque psoriasis and rheumatoid arthritis in the country, has announced the launch of Adalimumab’s biosimilar under a licensing agreement with Zydus group firm...
Biocon and Mylan’s proposed trastuzumab has received approval from Brazilian regulatory agency ANVISA, through their partner Libbs Farmaceutica (Libbs). The approved product is co-developed by Biocon...